FR2596991A1 - Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes - Google Patents
Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes Download PDFInfo
- Publication number
- FR2596991A1 FR2596991A1 FR8701057A FR8701057A FR2596991A1 FR 2596991 A1 FR2596991 A1 FR 2596991A1 FR 8701057 A FR8701057 A FR 8701057A FR 8701057 A FR8701057 A FR 8701057A FR 2596991 A1 FR2596991 A1 FR 2596991A1
- Authority
- FR
- France
- Prior art keywords
- film
- pharmaceutical product
- product according
- polymers
- active substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 22
- 239000007788 liquid Substances 0.000 title claims abstract description 14
- 201000004681 Psoriasis Diseases 0.000 title claims abstract description 12
- 239000013543 active substance Substances 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 17
- 229940127557 pharmaceutical product Drugs 0.000 claims abstract description 17
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004202 carbamide Substances 0.000 claims abstract description 15
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960002311 dithranol Drugs 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000003862 glucocorticoid Substances 0.000 claims abstract description 5
- 229940037128 systemic glucocorticoids Drugs 0.000 claims abstract description 4
- 230000002682 anti-psoriatic effect Effects 0.000 claims description 13
- 239000006185 dispersion Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 239000002085 irritant Substances 0.000 abstract 1
- 231100000021 irritant Toxicity 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 19
- 239000000725 suspension Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004283 Sodium sorbate Substances 0.000 description 4
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 4
- 235000019250 sodium sorbate Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YUTJCNNFTOIOGT-UHFFFAOYSA-N anthracene-1,8,9-triol Chemical compound C1=CC(O)=C2C(O)=C3C(O)=CC=CC3=CC2=C1 YUTJCNNFTOIOGT-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000007979 citrate buffer Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- POPFMWWJOGLOIF-XWCQMRHXSA-N Flurandrenolide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O POPFMWWJOGLOIF-XWCQMRHXSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960004511 fludroxycortide Drugs 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 238000006887 Ullmann reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000010952 in-situ formation Methods 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863612305 DE3612305A1 (de) | 1986-04-11 | 1986-04-11 | Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2596991A1 true FR2596991A1 (fr) | 1987-10-16 |
Family
ID=6298514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8701057A Withdrawn FR2596991A1 (fr) | 1986-04-11 | 1987-01-29 | Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4826677A (en:Method) |
| JP (1) | JPS62242614A (en:Method) |
| CH (1) | CH672598A5 (en:Method) |
| DE (1) | DE3612305A1 (en:Method) |
| FR (1) | FR2596991A1 (en:Method) |
| GB (1) | GB2188844B (en:Method) |
| NL (1) | NL8700814A (en:Method) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8729855D0 (en) * | 1987-12-22 | 1988-02-03 | Drythanol Ltd | New dithranol compositions |
| CA2008775C (en) * | 1989-02-24 | 1998-12-22 | Alberto Ferro | Nail lacquer |
| IN172390B (en:Method) * | 1989-07-18 | 1993-07-10 | Ethicon Inc | |
| JPH0794378B2 (ja) * | 1989-08-18 | 1995-10-11 | 久光製薬株式会社 | エアゾール剤 |
| US4996046A (en) * | 1989-11-24 | 1991-02-26 | Warshaw Thelma G | Infrared treatment for psoriasis |
| US5176912A (en) * | 1991-01-29 | 1993-01-05 | Orestes Cabezas | Method of treating psoriasis |
| US5650171A (en) * | 1992-04-29 | 1997-07-22 | Penederm, Inc. | Retinoic acid-containing polyether-polyurethane compositions |
| US5248494A (en) * | 1992-06-10 | 1993-09-28 | Young Pharmaceuticals Inc. | Method of reducing anthralin induced inflammation and staining |
| DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
| US5800831A (en) * | 1993-07-28 | 1998-09-01 | Pfizer Inc. | Psoriasis treatment with polymer film |
| WO1995003838A1 (en) * | 1993-07-28 | 1995-02-09 | Pfizer Inc. | Psoriasis treatment |
| US6113893A (en) * | 1993-07-28 | 2000-09-05 | Pfizer Inc. | Psoriasis treatment |
| AU702191B2 (en) * | 1993-08-19 | 1999-02-18 | Yale University | Cosmetic melanins |
| US5744125A (en) * | 1993-08-19 | 1998-04-28 | Yale University | Cosmetic melanins |
| US5776920A (en) * | 1995-08-02 | 1998-07-07 | Quarles; Ruth | Method for treatment of psoriasis |
| US5955081A (en) * | 1996-03-22 | 1999-09-21 | Moady Marzook | Antipsoriatic compositions, method of making, and method of using |
| DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
| RO118174B1 (ro) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Lac de unghii şi utilizarea acestuia |
| US5858372A (en) * | 1997-09-12 | 1999-01-12 | Jacob; George | Herbal medication for the treatment of psoriasis |
| JP2002527458A (ja) * | 1998-10-19 | 2002-08-27 | ジラ・インク | 体組織上に保護フィルム及び／又は薬用フィルムをインサイチュ（ｉｎｓｉｔｕ）形成するための方法及び組成物 |
| GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| ATE252380T1 (de) * | 1999-02-05 | 2003-11-15 | Cipla Ltd | Topische sprays enthaltend eine filmbildende zusammensetzung |
| US6962691B1 (en) | 1999-05-20 | 2005-11-08 | U & I Pharmaceuticals Ltd. | Topical spray compositions |
| IT1319210B1 (it) * | 2000-10-13 | 2003-09-26 | Italiano Biochimico Lisapharma | Pellicola per la somministrazione dermica e transdermica di principiattivi. |
| IL156458A0 (en) * | 2001-01-09 | 2004-01-04 | Therapeutic film forming composition | |
| US6942875B2 (en) * | 2001-07-05 | 2005-09-13 | Closure Medical Corporation | Adhesive treatment for skin yeast infections |
| US6767552B2 (en) | 2001-07-05 | 2004-07-27 | Closure Medical Corporation | Adhesive treatment for oral fungal infection |
| US6602496B2 (en) | 2001-07-05 | 2003-08-05 | Closure Medical Corporation | Adhesive treatment for tinea corporis |
| US6585967B2 (en) | 2001-07-05 | 2003-07-01 | Closure Medical Corporation | Adhesive treatment for tinea cruris |
| US6746667B2 (en) | 2001-07-05 | 2004-06-08 | Closure Medical Corporation | Adhesive treatment for tinea pedis |
| JP2004359585A (ja) * | 2003-06-03 | 2004-12-24 | Medorekkusu:Kk | 被膜形成型の副腎皮質ステロイド薬含有外用製剤 |
| CA2578999A1 (en) * | 2004-09-01 | 2006-03-16 | Trustees Of Boston University | Use of thyroid hormone conversion inhibitors |
| JP2006131544A (ja) * | 2004-11-05 | 2006-05-25 | Medorekkusu:Kk | 皮膚疾患治療用外用剤 |
| CN101180037A (zh) * | 2005-03-21 | 2008-05-14 | 莱夫克尔创新私人有限公司 | 一种新的层间和层内多层囊泡制品 |
| GB0518769D0 (en) | 2005-09-14 | 2005-10-19 | Medpharm Ltd | Topical formulations |
| EP2043663B1 (en) * | 2006-07-25 | 2014-03-19 | ITH Immune Therapy Holdings AB | Topical treatment of warts |
| US20140135372A1 (en) | 2010-02-02 | 2014-05-15 | Elliott Farber | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
| KR20150038212A (ko) * | 2012-07-23 | 2015-04-08 | 다우 글로벌 테크놀로지스 엘엘씨 | 경질 캡슐 쉘용 필름 조성물 |
| US9717741B2 (en) | 2012-10-11 | 2017-08-01 | Anaplasi Pharmaceuticals Llc | Method and compositions for treating psoriasis |
| ES2924084T3 (es) * | 2012-10-11 | 2022-10-04 | Chem Cure Ass Llc | Composición tópica para su uso en el tratamiento de la psoriasis |
| JP6224203B2 (ja) * | 2016-12-08 | 2017-11-01 | アナプラシ ファーマシューティカルズ エルエルシー | 乾癬を治療するための組成物 |
| JP6491293B2 (ja) * | 2017-10-04 | 2019-03-27 | アナプラシ ファーマシューティカルズ エルエルシー | 乾癬を治療するためのエアロゾル、ムース、又はフォームの組成物 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1467957A1 (de) * | 1964-02-18 | 1969-02-13 | Johnson & Johnson | Verfahren zur Herstellung therapeutisch wirksamer Zusammensetzungen zur Behandlung von Hautschaeden u.dgl. |
| GB1279294A (en) * | 1969-06-10 | 1972-06-28 | Lucien Nouvel | Surgical and skin dressings and excipients for use in forming them |
| GB1467957A (en) * | 1974-05-20 | 1977-03-23 | Hoke Inc | Mounting adaptor |
| GB1504007A (en) * | 1976-06-28 | 1978-03-15 | Dermal Lab Ltd | Compositions containing dithranol |
| EP0006724A1 (en) * | 1978-06-16 | 1980-01-09 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions containing urea |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| FR2515045A1 (fr) * | 1981-10-23 | 1983-04-29 | Cird | Matrice de diffusion polymerique a base d'anthraline ou de l'un de ses derives et son application dans le traitement des maladies de la peau |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4007271A (en) * | 1971-11-26 | 1977-02-08 | Sterling Drug Inc. | Dermatalogical compounds and compositions |
| US4496588A (en) * | 1977-07-11 | 1985-01-29 | Merrell Toraude Et Compagnie | Method of treating psoriasis |
| IL65588A (en) * | 1981-07-10 | 1985-04-30 | Orion Yhtymae Oy | Pharmaceutical compositions for the treatment of skin |
| GB2116423B (en) * | 1982-01-13 | 1986-08-28 | Quinoderm Ltd | Dermatological compositions |
| LU84979A1 (fr) * | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
-
1986
- 1986-04-11 DE DE19863612305 patent/DE3612305A1/de not_active Withdrawn
-
1987
- 1987-01-29 FR FR8701057A patent/FR2596991A1/fr not_active Withdrawn
- 1987-04-02 US US07/033,248 patent/US4826677A/en not_active Expired - Fee Related
- 1987-04-07 CH CH1339/87A patent/CH672598A5/de not_active IP Right Cessation
- 1987-04-07 NL NL8700814A patent/NL8700814A/nl not_active Application Discontinuation
- 1987-04-10 GB GB8708659A patent/GB2188844B/en not_active Expired - Fee Related
- 1987-04-10 JP JP62087264A patent/JPS62242614A/ja active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1467957A1 (de) * | 1964-02-18 | 1969-02-13 | Johnson & Johnson | Verfahren zur Herstellung therapeutisch wirksamer Zusammensetzungen zur Behandlung von Hautschaeden u.dgl. |
| GB1279294A (en) * | 1969-06-10 | 1972-06-28 | Lucien Nouvel | Surgical and skin dressings and excipients for use in forming them |
| GB1467957A (en) * | 1974-05-20 | 1977-03-23 | Hoke Inc | Mounting adaptor |
| GB1504007A (en) * | 1976-06-28 | 1978-03-15 | Dermal Lab Ltd | Compositions containing dithranol |
| EP0006724A1 (en) * | 1978-06-16 | 1980-01-09 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions containing urea |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| FR2515045A1 (fr) * | 1981-10-23 | 1983-04-29 | Cird | Matrice de diffusion polymerique a base d'anthraline ou de l'un de ses derives et son application dans le traitement des maladies de la peau |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62242614A (ja) | 1987-10-23 |
| GB2188844B (en) | 1990-11-21 |
| DE3612305A1 (de) | 1987-10-22 |
| NL8700814A (nl) | 1987-11-02 |
| CH672598A5 (en:Method) | 1989-12-15 |
| GB8708659D0 (en) | 1987-05-13 |
| US4826677A (en) | 1989-05-02 |
| GB2188844A (en) | 1987-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2596991A1 (fr) | Medicament sous forme liquide pour le traitement du psoriasis, a base de polymeres filmogenes | |
| Tanaji | Emulgel: A comprehensive review for topical delivery of hydrophobic drugs | |
| JP4067580B2 (ja) | 凍結乾燥バイオマトリックス | |
| CN111065415A (zh) | 药剂局部递送的平台及其配制方法 | |
| CA2310138A1 (fr) | Association prolamines-lipides polaires vegetaux, son procede de preparation et ses applications | |
| FR2582942A1 (fr) | Rubans medicaux adhesifs pour la muqueuse buccale | |
| FR2814074A1 (fr) | Nouvelles compositions estro-progestatives topiques a effet systemique | |
| FR2583638A1 (fr) | Formes de presentation solides, aptes a la conservation revetues d'une pellicule elastique | |
| JP2008501805A (ja) | 薬物の皮膚送達のための接着性外皮形成製剤とそれを使用する方法 | |
| Vanpariya et al. | Emulgel: A review | |
| CA2392402A1 (fr) | Dispositif transdermique comprenant un reservoir et une matrice contenant le meme principe actif | |
| BE1001932A4 (fr) | Compositions pharmaceutique facilitant la cicatrisation des blessures et procedes pour sa preparation. | |
| US4808415A (en) | Composition for the extemporary preparation of formulations for topical applications for pharmaceutical and cosmetic use | |
| WO2017025666A1 (fr) | Composition antidouleur comprenant un derive de l'acide salicylique | |
| FR2503561A1 (fr) | Film flexible continu a usage cosmetique et pharmaceutique contenant des polypeptides | |
| CN117797062A (zh) | 一种具有祛痘功效的油珠精华及其制备方法 | |
| FR2565103A1 (fr) | Composition pharmaceutique liberant graduellement de l'iode | |
| KR19980076273A (ko) | 경피흡수용 필름형성 겔 조성물 | |
| FR2571619A1 (fr) | Produit pharmaceutique depourvu de glucocorticoides pour le traitement local du psoriasis | |
| Patil et al. | Advances and challenges in serratiopeptidase topical formulation | |
| BE1014352A5 (fr) | Utilisation du diclofenac pour la fabrication d'un medicament topique pour traiter les brulures. | |
| LU84509A1 (fr) | Composition de cromoglycate de sodium,emballage et procede pour preparer la composition | |
| JPS6124524A (ja) | 膜組成物 | |
| BE1028251B1 (fr) | Emplâtre médical à libération lente | |
| FR2685204A1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |